The new EFPIA Disclosure Code – Is the Need for Transparency Outweighing Data Privacy Compliance?

February 2016Corporate Governance Pharmaceutical

Abstract

European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted on 24 June 2013, the EFPIA Disclosure Code, that is a code of conduct which obliges its member companies, from 2016, onwards, to make public the details of payments and transfers of value made to healthcare professionals (HCPs) and healthcare organizations (HCOs). The first disclosures will be made in June 2016 and will concern information about Transfers of Value ( ToV) made in 2015. In order to help its Members to be prepared for that obligation, EFPIA has launched a new website: --“Pharmadisclosure.eu”—aiming to highlight the new disclosure rules, follow best practices in the implementation of the Disclosure Code and monitor compliance in the 33 countries involved in the initiative (i.e. the 28 EU member states, plus Switzerland, Russia, Ukraine, Turkey and Serbia).

Subscribe to reador

Pharmaceutical Industry is very risky business, not only that the company needs to grow its profit but it must show to the people that they contribute to the human health...Read more

Tri Junanto Wicaksono

Head of GA & Legal, PT. Amerta Indah Otsuka, Indonesia

Conducting Effective Global Anti–Money Laundering Investigations in a Complex Regulatory Environment

Global anti–money laundering (AML) investigations present complex operational and regulatory challenges driven by cross-border transactions, fragmented data sources, varying legal regimes, data protection and privacy requirements, and cultural barriers to...Read more

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

Kwanza Burney

Compliance & Risk Professional | M.S.L. Candidate (Fordham Law), Fordham University School of Law, USA

The new EFPIA Disclosure Code – Is the Need for Transparency Outweighing Data Privacy Compliance?

Abstract

Related Papers